A look back at Pharma in 2010

With 2010 coming to a close, FiercePharma is publishing our annual year-in-review issue. We're taking a look back at the past 12 months to identify the major trends--such as recalls, settlements and the emerging markets grab--that shaped the pharma industry this year.

FiercePharma is taking our annual year-end break and won't be published tomorrow or the last week of December. But you can visit www.fiercepharma.com for breaking news or check out our special reports archive to catch up on articles you may have missed. We'll be back to our regular schedule on Monday, January 3rd and look forward to sharing another year of pharma news with you in 2011. Happy holidays! - Maureen (twitter | email)

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.